These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 5356869)

  • 21. [Biologic data furnished by the experience of thrombolytic treatments with streptokinase].
    Samama M; Yver J; Casubolo L; Soria J; Bousser J
    Nouv Rev Fr Hematol; 1968; 8(1):84-92. PubMed ID: 4232155
    [No Abstract]   [Full Text] [Related]  

  • 22. [Serum lipids following experimental fibrinolysis].
    Suschke J; Kunze D; von Pilar CE; Krejci K
    Monatsschr Kinderheilkd (1902); 1973 Jul; 121(7):388-9. PubMed ID: 4270871
    [No Abstract]   [Full Text] [Related]  

  • 23. Fibrinolysis.
    Sherry S
    Annu Rev Med; 1968; 19():247-68. PubMed ID: 4172727
    [No Abstract]   [Full Text] [Related]  

  • 24. [Late results following fibrinolysis therapy of venous thromboses].
    Breddin HK
    Internist (Berl); 1984 Feb; 25(2):102-7. PubMed ID: 6368451
    [No Abstract]   [Full Text] [Related]  

  • 25. [The fibrinolytic activity in Seegers' cattle prothrombin preparations. A contribution to the problem of the activation of cattle prothrombin by plasmin].
    Andrassy K; Egbring R; Egli H
    Thromb Diath Haemorrh; 1969 Nov; 22(2):377-90. PubMed ID: 4245334
    [No Abstract]   [Full Text] [Related]  

  • 26. Present-day thrombolytic therapy: therapeutic agents--pharmacokinetics and pharmacodynamics.
    Bell WR
    Rev Cardiovasc Med; 2002; 3 Suppl 2():S34-44. PubMed ID: 12556741
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Determination of the components of fibrinolytic system].
    Slobozhankina IK
    Lab Delo; 1973; 11():662-4. PubMed ID: 4132568
    [No Abstract]   [Full Text] [Related]  

  • 28. The present status of thrombolytic agents.
    Verstraete M
    Drugs; 1973; 5(5):353-6. PubMed ID: 4727866
    [No Abstract]   [Full Text] [Related]  

  • 29. Laboratory control of SK therapy.
    Conard J; Samama M
    Thromb Diath Haemorrh Suppl; 1973; 56():191-8. PubMed ID: 4805495
    [No Abstract]   [Full Text] [Related]  

  • 30. Comparison of the relative fibrinogenolytic, fibrinolytic and thrombolytic properties of tissue plasminogen activator and urokinase in vitro.
    Matsuo O; Rijken DC; Collen D
    Thromb Haemost; 1981 Jun; 45(3):225-9. PubMed ID: 7025339
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biochemical evaluation of low dose of urokinase in acute myocardial infarction. A double-blind study.
    Gormsen J; Tidstrom B; Feddersen C; Ploug J
    Acta Med Scand; 1973; 194(3):191-8. PubMed ID: 4583532
    [No Abstract]   [Full Text] [Related]  

  • 32. Thrombolysis with streptokinase in rabbits. Dose response, fibrin-clot specificity and laboratory evaluation of fibrinolytic effect.
    Nowak A; Gurewich V
    Thromb Diath Haemorrh; 1974 May; 31(2):265-72. PubMed ID: 4855199
    [No Abstract]   [Full Text] [Related]  

  • 33. Theoretical and practical aspects of thrombolytic therapy.
    Hirsh J
    Angiology; 1977 Jan; 28(1):1-6. PubMed ID: 326096
    [No Abstract]   [Full Text] [Related]  

  • 34. [Long-lasting activation of the fibrinolytic system in blood and its clinical application].
    Bielawiec M
    Pol Tyg Lek; 1969 Jan; 24(2):63-6. PubMed ID: 4240415
    [No Abstract]   [Full Text] [Related]  

  • 35. [Thrombolytics and their use].
    Alessi MC; Juhan-Vague I
    Rev Prat; 1999 Oct; 49(15):1654-8. PubMed ID: 10581996
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison between the changes in the plasma fibrinogen and plasminogen levels induced by a moderate or high initial dose of streptokinase.
    Amery A; Donati MB; Vermylen J; Verstraete M
    Thromb Diath Haemorrh; 1970 Jun; 23(3):504-12. PubMed ID: 5432192
    [No Abstract]   [Full Text] [Related]  

  • 37. [When is fibrinolytic therapy indicated?].
    Woitinas F
    Med Klin; 1980 Feb; 75(3):98-107. PubMed ID: 6990218
    [No Abstract]   [Full Text] [Related]  

  • 38. [Molecular mechanisms of fibrinolysis and perspectives of thrombolytic therapy].
    Veremeenko KN; Kizim AI
    Vopr Med Khim; 1984; 30(5):13-22. PubMed ID: 6084892
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Contemporary data on the human fibrinolytic system].
    Andreenko GV
    Klin Med (Mosk); 1970 Oct; 48(10):16-24. PubMed ID: 4252327
    [No Abstract]   [Full Text] [Related]  

  • 40. [Monitoring fibrinolytic treatment].
    Rodzynek JJ
    Rev Med Brux; 1983 Jan; 4(1):32-3. PubMed ID: 6836205
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.